Pain, Neuropathic
58
6
6
26
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.9%
4 terminated out of 58 trials
86.7%
+0.2% vs benchmark
10%
6 trials in Phase 3/4
19%
5 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (58)
Prevalence of Pain in Hospitalized Cirrhotic Patients
Pain Phenotypes in Patients With Fibromyalgia Syndrome
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain
Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury
Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers
Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)
Dexmedetomidine in TAP Block for Inguinal Hernia Repair
Caregiver Burden and Correlation With Clinical Outcome in Spinal Cord Stimulation for Chronic Neuropathic Pain
Surgical Treatments for Neuroma Pain in Amputees
Pregabalin Treatment for RDEB Pain and Itch
Surgical Treatments for Postamputation Pain
Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial
Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation
Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.
Feasibility of Using an App for Managing Phantom Limb Pain Associated with Combat Injury in Ukraine (PAMELA)
Safety and Tolerability of NTRX-07 in Healthy Volunteers
Coordinated Reset Spinal Cord Stimulation
Distal Peripheral Neuropathy in Type 2 Diabetes
Effect of Cannabinoids on Pain in Fabry Disease Patients